Astrocyte-selective AAV gene therapy through the endogenous GFAP promoter results in robust transduction in the rat spinal cord following injury

Astrocyte-selective AAV gene therapy through the endogenous GFAP promoter results in robust transduction in the rat spinal cord following injuryAstrocyte-selective AAV gene therapy through the endogenous GFAP promoter results in robust transduction in the rat spinal cord following injury, Published online: 08 April 2019; doi:10.1038/s41434-019-0075-6Astrocyte-selective AAV gene therapy through the endogenous GFAP promoter results in robust transduction in the rat spinal cord following injury

Source: Gene Therapy - April 7, 2019 Category: Genetics & Stem Cells Authors: Jarred M. Griffin Barbara Fackelmeier Dahna M. Fong Alexander Mouravlev Deborah Young Simon J. O ’Carroll Source Type: research